Go Back Go Back
Go Back Go Back
Go Back Go Back

Frequently Asked Questions by ASHAs about DMPA (Depot Medroxy Progesterone Acetate) - Hindi

Frequently Asked Questions by ASHAs about DMPA (Depot Medroxy Progesterone Acetate) - Hindi
Frequently Asked Questions by ASHAs about DMPA (Depot Medroxy Progesterone Acetate) - Hindi

Publisher

Number of pages

11

Author

UNFPA India

Publication

Frequently Asked Questions by ASHAs about DMPA (Depot Medroxy Progesterone Acetate) - Hindi

Publication date

28 December 2018

Download Icon

The Government of India introduced three new contraceptives in its public health system in 2016. UNFPA India has been assisting the Government of India in roll out of new contraceptives, including injectable contraceptives, and in ensuring high quality services. This publication has been developed to address the questions frequently asked by ASHAs or similar level front line health worker or volunteer on injectable contraceptives (DMPA).

The purpose of this FAQ is to help ASHA/community worker to provide correct information with regards to DMPA/ Injectable Contraceptive and enable women to make informed choice. The questions contained in this document have been compiled on the basis of questions or concerns raised by ASHAs from different states during field-level interactions.